Login / Signup

Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review.

Michelle E PrattFarhan MahmoodMark G Kirchhof
Published in: Journal of cutaneous medicine and surgery (2021)
Idiopathic chilblains is a cold-induced inflammatory condition that causes significant morbidity. When preventative measures alone are inadequate, oral nifedipine is generally recommended as first-line pharmacologic therapy. Given the natural course of this spontaneously remitting/relapsing condition, controls are needed to critically appraise studies and determine the value of treatments. We report a systematic review of placebo-controlled or comparative therapeutic trials for the treatment of idiopathic chilblains. Our search of PubMed, Embase, and Cochrane databases, identified 11 studies that met our inclusion criteria for a combined study population n = 576. Therapies included nifedipine, pentoxifylline, tadalafil, topical glyceryl trinitrate (GTN), topical minoxidil, diltiazem, corticosteroids, and vitamin D. There was moderate evidence to support the use of nifedipine and pentoxifylline in the treatment of severe or refractory cases of idiopathic chilblains, while other therapies had inadequate evidence or nonsignificant results compared to placebo.
Keyphrases
  • multiple sclerosis
  • stem cells
  • randomized controlled trial
  • oxidative stress
  • high intensity
  • study protocol
  • mesenchymal stem cells
  • combination therapy
  • tyrosine kinase
  • rheumatoid arthritis
  • double blind
  • big data